-+ 0.00%
-+ 0.00%
-+ 0.00%

Barclays Maintains Overweight on Strategy, Raises Price Target to $160

Benzinga·09/15/2026 12:39:07
Listen to the news
Barclays analyst Nik Cremo maintains Strategy (NASDAQ:MSTR) with a Overweight and raises the price target from $125 to $160.